Eurofins CDMO Alphora Inc.
$22,439,200.00 CAD
- Program
- SIF Stream2- Growth
- Recipient country
- Canada
- Fiscal year
- 2022-2023
- Agreement period
- January 4, 2023 – January 1, 2046
- Reference
- ic:033-2023-2024-Q4-819623
Published purpose
This project will support the establishment of a biomanufacturing and development facility that is focused on mammalian cell culture. The facility will manufacture and produce antibody-based therapeutics and other protein biologics.
In plain English AI-generated
This project funds the establishment of a biomanufacturing facility in Canada focused on producing antibody-based therapeutics and protein biologics using mammalian cell culture.
Category: Health Primarily funds activity in Canada
Based on the published description. See how AI categorization works — the linked official record is authoritative.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.